Almirall, LLC et al v. Taro Pharmaceuticals, Inc.
Delaware District Court | |
Judge: | Colm F Connolly |
Case #: | 1:25-cv-00385 |
Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
Cause | 35:271 Patent Infringement |
Case Filed: | Mar 28, 2025 |
Last checked: Friday Mar 28, 2025 3:15 PM EDT |
Defendant
Taro Pharmaceuticals, Inc.
|
|
Plaintiff
ATNX SPV, LLC
|
Represented By
|
Plaintiff
Almirall, LLC
|
Represented By
|
Plaintiff
Almirall, S.A.
|
Represented By
|
Docket last updated: 2 hours ago |
Monday, April 07, 2025 | ||
10 | 10
![]() WAIVER OF SERVICE returned executed by Almirall, S.A., Almirall, LLC, ATNX SPV, LLC: For Taro Pharmaceuticals, Inc. waiver sent on 3/28/2025, answer due 5/27/2025. (Raucci, Anthony) |
|
utility
Add Attorneys - PHV only
Mon 04/07 10:24 AM
Pro Hac Vice Attorney James S. Trainor, Jr for ATNX SPV, LLC, Almirall, LLC, Almirall, S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) |
||
Friday, April 04, 2025 | ||
9 | 9
misc
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
Fri 04/04 12:37 PM
Pro Hac Vice Fee - Credit Card Payment received for James S. Trainor and Retley G. Locke, Jr.. ( re8 MOTION for Pro Hac Vice Appearance of Attorney James S. Trainor and Retley G. Locke, Jr. )( Payment of $ 100, receipt number ADEDC-4654401).(Raucci, Anthony) |
|
8 | 8
![]() MOTION for Pro Hac Vice Appearance of Attorney James S. Trainor and Retley G. Locke, Jr. - filed by ATNX SPV, LLC, Almirall, LLC, Almirall, S.A.. (Raucci, Anthony) |
|
order
SO ORDERED
Fri 04/04 12:45 PM
SO ORDERED, re8 MOTION for Pro Hac Vice Appearance of Attorney James S. Trainor and Retley G. Locke, Jr., filed by ATNX SPV, LLC, Almirall, S.A., Almirall, LLC. Ordered by Judge Colm F. Connolly on 4/4/2025. (kmd) |
||
utility
Add Attorneys - PHV only
Fri 04/04 3:35 PM
Pro Hac Vice Attorney Retley Locke for ATNX SPV, LLC, Almirall, LLC, and Almirall, S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) |
||
Wednesday, April 02, 2025 | ||
7 | 7
![]() STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) |
|
utility
Case Assigned/Reassigned
Wed 04/02 11:30 AM
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
||
Friday, March 28, 2025 | ||
6 | 6
![]() Summons Issued as to Taro Pharmaceuticals, Inc. on 3/28/2025. (jfm) |
|
5 | 5
![]() Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sagard Healthcare Royalty Partners, LP for ATNX SPV, LLC; Other Affiliate Almirall, S.A. for Almirall, LLC - filed by ATNX SPV, LLC, Almirall, LLC, Almirall, S.A. (jfm) |
|
4 | 4
![]() Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,300,931 B2; 7,851,470 B2; 10,323,001 B2; 10,617,693 B2 ; 10,669,236 B2; 11,497,750 B2. (jfm) |
|
3 | 3
![]() Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/15/2025. Date of Expiration of Patent: U.S. Patent No. 7,300,931 will expire on 02/06/2026; U.S. Patent No. 7,851,470 will expire on 02/02/2029; U.S. Patent No. 10,323,001 will expire on 12/28/2027; U.S. Patent No. 0,617,693 will expire on 03/12/2038; U.S. Patent No. 10,669,236 will expire on 09/07/2038; U.S. Patent No. 11,497,750 will expire on 03/12/2038. Thirty Month Stay Deadline: 6/14/2028. (jfm) |
|
2 | 2
![]() Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
|
1 | 1
![]() COMPLAINT for Patent Infringement against Taro Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4648665) - filed by Almirall, S.A., Almirall, LLC, ATNX SPV, LLC.(jfm) |
|
Att: 1
![]() |
||
Att: 2
![]() |